Mirati Therapeutics, Inc. Information Request Form
Levi & Korsinsky announces it has commenced an investigation of Mirati Therapeutics, Inc. (NASDAQ: MRTX) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.